Literature DB >> 28082297

Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline.

Patricia A Boyle1,2, Jingyun Yang1,3, Lei Yu1,3, Sue E Leurgans1,3, Ana W Capuano1,3, Julie A Schneider1,3,4, Robert S Wilson1,2,3, David A Bennett1,3.   

Abstract

The objective of this study was to examine whether the effects of age-related neuropathologies on cognition change over time. Participants were 1096 deceased persons from two clinical-pathologic studies. All were without dementia at baseline, completed a detailed battery of cognitive tests annually over up to 21 years, died, and underwent detailed neuropathologic examinations to identify Alzheimer's disease pathology, vascular pathologies (i.e. macro- and microscopic infarcts, atherosclerosis, arteriolar sclerosis, and cerebral amyloid angiopathy), Lewy bodies, transactive response DNA-binding protein 43 (TDP-43) pathology, and hippocampal sclerosis. A time-varying effects model was used to flexibly characterize the trajectory of global cognition and assess whether the effects of demographics and each neuropathologic index on cognition changed over time. Results indicated that the mean trajectory of global cognition was characterized by gradual cognitive decline beginning ∼15 years before death and accelerated decline in the last few years. With the exception of microinfarcts and arteriolar sclerosis, all neuropathologies were associated with the cognitive trajectory. However, the nature of their associations varied. Alzheimer's disease pathology, macroscopic infarcts, Lewy bodies, TDP-43 pathology, and hippocampal sclerosis were associated with progressive cognitive decline, with their deleterious effects increasing over time. By contrast, atherosclerosis and cerebral amyloid angiopathy pathology were associated with a lower level of cognition but their effects were relatively stable over time. These results suggest that age-related neuropathologies are differentially related to late life cognitive trajectories. Whereas some contribute to progressive cognitive deterioration, others lower the level of cognition but exert relatively stable effects over time.
© The Author (2017). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s; TDP-43; cognitive ageing; neuropathology; small vessel disease

Mesh:

Year:  2017        PMID: 28082297      PMCID: PMC5837473          DOI: 10.1093/brain/aww341

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  29 in total

1.  Conscientiousness, dementia related pathology, and trajectories of cognitive aging.

Authors:  Robert S Wilson; Patricia A Boyle; Lei Yu; Eisuke Segawa; Joel Sytsma; David A Bennett
Journal:  Psychol Aging       Date:  2015-02-09

2.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

3.  Terminal decline and practice effects in older adults without dementia: the MoVIES project.

Authors:  Hiroko H Dodge; Chia-Ning Wang; Chung-Chou H Chang; Mary Ganguli
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

4.  Using the time-varying effect model (TVEM) to examine dynamic associations between negative affect and self confidence on smoking urges: differences between successful quitters and relapsers.

Authors:  Mariya P Shiyko; Stephanie T Lanza; Xianming Tan; Runze Li; Saul Shiffman
Journal:  Prev Sci       Date:  2012-06

5.  Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly.

Authors:  Ira Driscoll; Susan M Resnick; Juan C Troncoso; Yang An; Richard O'Brien; Alan B Zonderman
Journal:  Ann Neurol       Date:  2006-12       Impact factor: 10.422

6.  Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.

Authors:  Sukriti Nag; Lei Yu; Ana W Capuano; Robert S Wilson; Sue E Leurgans; David A Bennett; Julie A Schneider
Journal:  Ann Neurol       Date:  2015-04-22       Impact factor: 10.422

7.  Relation of neuropathology to cognition in persons without cognitive impairment.

Authors:  David A Bennett; Robert S Wilson; Patricia A Boyle; Aron S Buchman; Julie A Schneider
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

Review 8.  Neuropathologic alterations in mild cognitive impairment: a review.

Authors:  William R Markesbery
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

9.  Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.

Authors:  Patricia A Boyle; Lei Yu; Sukriti Nag; Sue Leurgans; Robert S Wilson; David A Bennett; Julie A Schneider
Journal:  Neurology       Date:  2015-11-04       Impact factor: 9.910

10.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06
View more
  48 in total

1.  Association Between Brain Gene Expression, DNA Methylation, and Alteration of Ex Vivo Magnetic Resonance Imaging Transverse Relaxation in Late-Life Cognitive Decline.

Authors:  Lei Yu; Robert J Dawe; Patricia A Boyle; Chris Gaiteri; Jingyun Yang; Aron S Buchman; Julie A Schneider; Konstantinos Arfanakis; Philip L De Jager; David A Bennett
Journal:  JAMA Neurol       Date:  2017-12-01       Impact factor: 18.302

2.  Neuropsychological latent classes at enrollment and postmortem neuropathology.

Authors:  Andrea R Zammit; Charles B Hall; David A Bennett; Ali Ezzati; Mindy J Katz; Graciela Muniz-Terrera; Richard B Lipton
Journal:  Alzheimers Dement       Date:  2019-08-13       Impact factor: 21.566

3.  Person-Specific Contributions of Brain Pathologies to Progressive Parkinsonism in Older Adults.

Authors:  Aron S Buchman; Lei Yu; Shahram Oveisgharan; Jose M Farfel; Julie A Schneider; David A Bennett
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-03-31       Impact factor: 6.053

4.  Combined neuropathological pathways account for age-related risk of dementia.

Authors:  Melinda C Power; Elizabeth Mormino; Anja Soldan; Bryan D James; Lei Yu; Nicole M Armstrong; Katherine J Bangen; Lisa Delano-Wood; Melissa Lamar; Yen Ying Lim; Kelly Nudelman; Laura Zahodne; Alden L Gross; Dan Mungas; Keith F Widaman; Julie Schneider
Journal:  Ann Neurol       Date:  2018-06-26       Impact factor: 10.422

5.  Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health.

Authors:  Mary Ganguli; Emiliano Albanese; Sudha Seshadri; David A Bennett; Constantine Lyketsos; Walter A Kukull; Ingmar Skoog; Hugh C Hendrie
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Jan-Mar       Impact factor: 2.703

Review 6.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

7.  How do we validate approaches that aim to harness reserve to improve the aging brain?

Authors:  Lon R White; Patricia A Boyle; Thomas C Foster; Adam H Gazzaley; John F Disterhoft
Journal:  Neurobiol Aging       Date:  2019-11       Impact factor: 4.673

8.  Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; Amanda M Serie; Ralph B Perkerson; Billie J Matchett; Clifford R Jack; David S Knopman; Ronald C Petersen; Joseph E Parisi; Leonard Petrucelli; Matthew Baker; Rosa Rademakers; Jennifer L Whitwell; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2019-01-02       Impact factor: 17.088

9.  Heterogeneity of structural and functional imaging patterns of advanced brain aging revealed via machine learning methods.

Authors:  Harini Eavani; Mohamad Habes; Theodore D Satterthwaite; Yang An; Meng-Kang Hsieh; Nicolas Honnorat; Guray Erus; Jimit Doshi; Luigi Ferrucci; Lori L Beason-Held; Susan M Resnick; Christos Davatzikos
Journal:  Neurobiol Aging       Date:  2018-06-15       Impact factor: 4.673

10.  TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.

Authors:  Margaret E Flanagan; Brenna Cholerton; Caitlin S Latimer; Laura S Hemmy; Steven D Edland; Kathleen S Montine; Lon R White; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.